Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry.

被引：0
|
作者：
Toomey, Kathleen
Gasparetto, Cristina
Shah, Jatin J.
Abonour, Rafat
Mehta, Jayesh
Narang, Mohit
Terebelo, Howard R.
Hardin, James W.
Srinivasan, Shankar
Larkins, Gail
Ricafort, Rosanna J.
Nagarwala, Yasir M.
Rifkin, Robert M.
机构：
[1] Steeplechase Canc Ctr, Somerville, NJ USA
[2] Duke Univ, Durham, NC USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Maryland Oncol Hematol, Columbia, MD USA
[7] Providence Hosp, Southfield, MI 48037 USA
[8] Univ S Carolina, Columbia, SC 29208 USA
[9] Celgene Corp, Summit, NJ USA
[10] US Oncol Res Inc, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19529
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world outcomes (RWO) with tandem transplantation in patients (pts) with newly diagnosed multiple myeloma (NDMM)
    Parmar, Harsh
    Barcellos, Anna
    Biran, Noa
    Phull, Pooja
    Vesole, David H.
    Belli, Andrew J.
    Fernandes, Laura L.
    Hansen, Eric
    Zettler, Christina
    Wang, Ching-Kun
    Goran, Stefanie
    Anderson, Courtney
    Doucette, Kimberley
    Gunning, Thomas S.
    Ip, Andrew
    Siegel, David Samuel DiCapua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
    Ailawadhi, Sikander
    Lee, Hans C.
    Omel, James
    Toomey, Kathleen
    Hardin, James W.
    Gasparetto, Cristina J.
    Jagannath, Sundar
    Rifkin, Robert M.
    Durie, Brian G. M.
    Narang, Mohit
    Terebelo, Howard R.
    Joshi, Prashant
    Jou, Ying-Ming
    Mouro, Jorge
    Yu, Edward
    Abonour, Rafat
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [33] Real-world economic outcomes of early progression in newly diagnosed multiple myeloma (NDMM) patients (Pts).
    Clancy, Zoe
    Pandya, Shivani
    Shrestha, Sulena
    Wang, Li
    Baser, Onur
    Ni, Quanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [34] Myeloma XI Trial - Second Primary Malignancy Interim Report in Newly Diagnosed Multiple Myeloma (NDMM) Patients
    Jones, John
    Pawlyn, Charlotte
    Brioli, Annamaria
    Cairns, David A.
    Quartillo, Ana
    Sigsworth, Rachel
    Howard, Helen
    Collett, Corinne
    Ouzman, Jacqueline
    Gregory, Walter
    Russell, Nigel
    Jacksons, Graham H.
    Davies, Faith E.
    Morgan, Gareth J.
    BLOOD, 2014, 124 (21)
  • [35] Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)
    Maia, Catarina
    Puig, Noemi
    Perez Ruiz, Cristina
    Cedena Romero, Maria Teresa
    Guerrero, Camila
    Larrayoz, Marta
    Botta, Cirino
    Gutierrez, Norma C.
    Calasanz, Maria Jose
    Luisa Martin-Ramos, Maria
    Hernandez, Miguel
    Rosinol Dachs, Laura
    Gonzalez Garcia, Esther
    De Arriba, Felipe
    Oriol, Albert
    Gonzalez-Calle, Veronica
    Escalante, Fernando
    de la Rubia, Javier
    Gironella Mesa, Mercedes
    Rios, Rafael
    Garcia Sanchez, Ricarda Belen
    Arguinano Perez, Jose Maria
    Alegre, Adrian
    Martin, Jesus
    Couto Caro, Maria del Carmen
    Casanova, Maria
    Arnao Herraiz, Mario
    Perez, Ernesto
    Garzon Lopez, Sebastian
    Gonzalez Perez, Marta Sonia
    Martin-Nunez, Guillermo
    Rossi, Adriana
    Coleman, Morton
    Encinas, Cristina
    Vale, Ana M.
    Isabel Teruel, Ana
    Cortes Rodriguez, Maria
    Martinez-Climent, Jose A.
    Lahuerta, Juan-Jose
    Blade Creixenti, Joan
    Niesvizky, Ruben
    San-Miguel, Jesus
    Mateos, Maria-Victoria
    Paiva, Bruno
    BLOOD, 2022, 140 : 4200 - 4203
  • [36] Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study
    Usmani, Saad Z.
    Hungria, Vania T. M.
    Leleu, Xavier
    Lee, Hans C.
    Davies, Faith E.
    Costello, Caitlin L.
    Rifkin, Robert M.
    Weisel, Katja
    Chari, Ajai
    Puig, Noemi
    Boccadoro, Mario
    Cook, Gordon
    Berdeja, Jesus G.
    Zonder, Jeffrey A.
    Thompson, Michael A.
    Abonour, Rafat
    Vela-Ojeda, Jorge
    Hajek, Roman
    Spencer, Andrew
    Omel, Jim
    Demers, Brittany
    Romanus, Dorothy
    Ren, Kaili
    Skacel, Tomas
    Stull, Dawn Marie
    Terpos, Evangelos
    BLOOD, 2018, 132
  • [37] HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): THE FIRST TRIAL
    Delforge, M.
    Minuk, L.
    Eisenmann, J. C.
    Arnulf, B.
    Canepa, L.
    Fragasso, A.
    Leyvraz, S.
    Langer, C.
    Ezaydi, Y.
    Vogl, D. T.
    Giraldo-Castellano, P.
    Yoon, S. S.
    Martins, A.
    Zarnitsky, C.
    Escoffre-Barbe, M.
    Lemieux, B.
    Proskorovsky, I.
    Monzini, M. Silva
    Ervin-Haynes, A.
    Houck, V.
    Facon, T.
    HAEMATOLOGICA, 2014, 99 : 109 - 110
  • [38] Changes in patient-reported outcomes in patients diagnosed with and treated for multiple myeloma in the Connect MM registry
    Pashos, Chris L.
    Shah, Jatin J.
    Terebelo, Howard R.
    Durie, Brian G.
    Abonour, Rafat
    Gasparetto, Cristina
    Mehta, Jayesh
    Narang, Mohit
    Thomas, Sachdev
    Toomey, Kathleen
    Swern, Arlene S.
    Sullivan, Kristen A.
    Street, Thomas K.
    Khan, Zeba M.
    Nourbakhsh, Ali
    Hardin, James
    Wildes, Tanya Marya
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Daratumumab (DARA) plus Lenalidomide/Bortezomib/Dexamethasone (RVd) in African American/Black Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of GRIFFIN
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Rodriguez, Cesar
    Jakubowiak, Andrzej
    Shune, Leyla
    Badros, Ashraf
    Chari, Ajai
    Richardson, Paul G.
    Pei, Huiling
    Ukropec, Jon
    Vermeulen, Jessica
    Hoehn, Daniela
    Lin, Thomas S.
    Voorhees, Peter M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S308 - S309
  • [40] Biologic and clinical evaluation of rituxan (RT) in the management of newly diagnosed multiple myeloma (MM) patients(pts).
    Hussein, MA
    Karam, MA
    McLain, DA
    Elson, P
    Hsi, E
    BLOOD, 1999, 94 (10) : 313A - 313A
12345